Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Priming with either rocuronium or MgSO4 is known to accelerate the effect of rocuronium on muscle relaxation. The purpose of this study is to define the effect of MgSO4 on the rocuronium-priming.
Acceleration of muscle relaxation is beneficial in rapid-sequence intubation. If MgSO4 combined with priming is efficient in accelerating muscle relaxation, it would be an interesting alternative to rapid-sequence intubation.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Roc | No Intervention | Patients in this group receive neither MgSO4 nor priming dose of rocuronium. | |
| priming | Active Comparator | patients in this group receive 0.06mg/kg of rocuronium before 0.54mg/kg of rocuronium. |
|
| Mg&priming | Experimental | Patients in this group receive MgSO4 50mg/kg and 0.06mg/kg of rocuronium before administration of 0.54mg/kg of rocuronium. |
|
| MgSO4 | Active Comparator | Patients in this group receive intravenous MgSO4 before administration of rocuronium. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| magnesium sulfate | Drug | Patients in this group receive intravenous MgSO4 50mg/kg before administration of rocuronium (induction dose). |
|
| Measure | Description | Time Frame |
|---|---|---|
| time from injection of induction dose of rocuronium until 95% depression of TOF | time from injection of induction dose of rocuronium until 95% depression of TOF, upto 5 min |
| Measure | Description | Time Frame |
|---|---|---|
| rocuronium duration | time from injection of induction dose of rocuronium until train-of-four count reaches two. | time from injection of induction dose of rocuronium until train-of-four count reaches two. |
| intubating condition |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Mihyun Kim, MD | Contact | 82-31-787-2034 | snmd56@yahoo.com |
| Name | Affiliation | Role |
|---|---|---|
| Sanghwan Do, M.D., PH.D. | Seoul National University Bundang Hospital | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Seoul national university Bundang hospital | Recruiting | Seongnam | Kyoung-ki-do | 463-707 | South Korea |
Not provided
| ID | Term |
|---|---|
| D008278 | Magnesium Sulfate |
| ID | Term |
|---|---|
| D017616 | Magnesium Compounds |
| D007287 | Inorganic Chemicals |
| D013431 | Sulfates |
| D013464 | Sulfuric Acids |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| priming | Drug | Patients in this group receive 0.06mg/kg of rocuronium before administration of 0.54mg/kg of rocuronium. |
|
|
| magnesium sulfate and priming | Drug | Patients in this group receive MgSO4 50mg/kg and 0.06mg/kg of rocuronium before administration of 0.54mg/kg of rocuronium. |
|
|
rapid sesequence intubation condition is evaluated.
| time from injection of induction dose of rocuronium until tracheal intubation. |
| D013456 |
| Sulfur Acids |
| D013457 | Sulfur Compounds |